poisar

Stocks · News reference

Dave Outperforms Visa And Chime, Analyst Says

BenzingaPriya Nigam

JPMorgan starts Dave at Overweight with a $480 target, citing 25%+ growth, ~45% margins, a lean model and strong liquidity-product demand.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    NU Stock Rallies 23% in October: Is There Still Room for More Gains?

    Nu Holdings (NU) rallied 23.1% in October following Brazil's presidential election and the company's first billion-dollar quarterly profit. With 139 million customers and expanding operations in Mexico and the U.S., NU trades at a reasonable valuation discount to peers. However, rising delinquencies and U.S. expansion costs present risks, warranting a cautious approach for investors.

  2. Zacks Investment ResearchZacks Investment Research

    The Zacks Analyst Blog Highlights Chime Financial, Marqeta and Kronos

    As Q3 earnings season begins, three stocks stand out with projected earnings growth exceeding 100%: Chime Financial, Marqeta, and Kronos Worldwide. All three companies have received upward estimate revisions and demonstrated strong earnings surprises in recent quarters, supported by a broader earnings outlook showing S&P 500 earnings expected to grow 24.6% year-over-year.